Current state of knowledge on primary Sjögren's syndrome, an autoimmune exocrinopathy

D Parisis, C Chivasso, J Perret, MS Soyfoo… - Journal of clinical …, 2020 - mdpi.com
Primary Sjögren's syndrome (pSS) is a chronic systemic autoimmune rheumatic disease
characterized by lymphoplasmacytic infiltration of the salivary and lacrimal glands, whereby …

Sjögren's syndrome

I Thorne, N Sutcliffe - British Journal of Hospital Medicine, 2017 - magonlinelibrary.com
Sjögren's syndrome | British Journal of Hospital Medicine MAG Online Library Skip main
navigation Home Journals AZ Collections MAH Complete MAH Core Health Professionals …

Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary …

E Mossel, K Delli, JF van Nimwegen, AJ Stel… - Annals of the …, 2017 - ard.bmj.com
Objective To assess the validity of ultrasound of major salivary glands (sUS) compared with
parotid and labial gland biopsies, sialometry, anti-SSA/Ro antibody status and classification …

A biomarker for lymphoma development in Sjogren's syndrome: salivary gland focus score

L Chatzis, AV Goules, V Pezoulas, C Baldini… - Journal of …, 2021 - Elsevier
The aim of this study is to explore the role of labial minor salivary gland (LMSG) focus score
(FS) in stratifying Sjögren's Syndrome (SS) patients, lymphoma development prediction and …

Innate immunity and biological therapies for the treatment of Sjögren's syndrome

A Srivastava, HP Makarenkova - International journal of molecular …, 2020 - mdpi.com
Sjögren's syndrome (SS) is a systemic autoimmune disorder affecting approximately 3% of
the population in the United States. This disease has a female predilection and affects …

[PDF][PDF] One year in review 2016: Sjögren's syndrome

F Ferro, R Vagelli, C Bruni, G Cafaro… - Clin Exp …, 2016 - clinexprheumatol.org
Sjögren's syndrome (SS) is a complex heterogeneous disease charactered by a broad
spectrum of clinical and serological manifestations, including non-Hodgkin's lymphoma …

Immunopathogenesis of Sjogren's syndrome: Current state of DAMPs

B Ming, Y Zhu, J Zhong, L Dong - Seminars in Arthritis and Rheumatism, 2022 - Elsevier
Sjögren's syndrome (SS) is a systemic autoimmune disorder with an estimated global
prevalence of 0.3 to 1/1000 persons. This disease has a female predilection and mainly …

[HTML][HTML] Extracellular matrix turnover in salivary gland disorders and regenerative therapies: Obstacles and opportunities

M Marinkovic, ON Tran, H Wang, P Abdul-Azees… - Journal of Oral Biology …, 2023 - Elsevier
Salivary gland (SG) extracellular matrix (ECM) has a major influence on tissue development,
homeostasis, and tissue regeneration after injury. During aging, disease, and physical insult …

Management of rheumatic complications of immune checkpoint inhibitor therapy–an oncological perspective

NM Steven, BA Fisher - Rheumatology, 2019 - academic.oup.com
Immune checkpoint inhibitors (CPIs) are an effective treatment for many cancers but cause
diverse immune-related adverse events (IrAEs). Rheumatological IrAEs include arthralgia …

Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome

S Nayar, J Campos, CG Smith, V Iannizzotto… - Annals of the …, 2019 - ard.bmj.com
Background The phosphatidylinositol 3-kinase delta isoform (PI3Kδ) belongs to an
intracellular lipid kinase family that regulate lymphocyte metabolism, survival, proliferation …